Video

What's Next For Computational Biology In Biotech?

Source: Cytiva

In this final segment of our Bioprocess Online Live event, How Computational Biology Speeds Drug Discovery, Development, EVQLV CEO and Co-Founder Andrew Satz and Recursion President & COO Tina Larson share what they’re doing next—and where they see the industry going next—in terms of the adoption and impact of AI and ML in drug discovery and development.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva